Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Cascadian Therapeutics Inc (CASC)

Cascadian Therapeutics Inc (CASC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 507,212
  • Shares Outstanding, K 50,620
  • Annual Sales, $ 0 K
  • Annual Income, $ -56,930 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 3.80
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 4.65
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.88
  • Most Recent Earnings $-0.28 on 11/08/17
  • Next Earnings Date 03/08/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/17
See More
  • Average Estimate -0.29
  • Number of Estimates 2
  • High Estimate -0.29
  • Low Estimate -0.29
  • Prior Year -0.47
  • Growth Rate Est. (year over year) +38.30%

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.96 +0.20%
on 02/22/18
10.03 -0.50%
on 03/08/18
-0.01 (-0.10%)
since 02/09/18
3-Month
3.52 +183.52%
on 01/08/18
10.21 -2.25%
on 01/31/18
+6.10 (+157.22%)
since 12/08/17
52-Week
3.18 +213.84%
on 06/15/17
10.21 -2.25%
on 01/31/18
+5.84 (+141.06%)
since 03/09/17

Business Summary

Cascadian Therapeutics, Inc. is a biopharmaceutical company specializing in developing innovative therapeutic product candidates for the treatment of cancer. The company's product candidate is ONT-380, an orally active and selective small molecule HER2 inhibitor which is in preclinical trial stage. Cascadian...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 10.05
1st Resistance Point 10.04
Last Price 9.98
1st Support Level 10.00
2nd Support Level 9.97
3rd Support Level N/A

See More

52-Week High 10.21
Last Price 9.98
Fibonacci 61.8% 7.52
Fibonacci 50% 6.70
Fibonacci 38.2% 5.87
52-Week Low 3.18

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar